John Milton

Technik-/Wissenschafts-/F&E-Leiter bei OXFORD NANOPORE TECHNOLOGIES PLC

Health Technology

Electronic Technology

Commercial Services

Aktive Positionen von John Milton

Unternehmen	Position	Beginn	Ende
OXFORD NANOPORE TECHNOLOGIES PLC	Technik-/Wissenschafts-/F&E-Leiter	-	-

Unternehmen	Position	Beginn	Ende
Solexa Ltd. Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2001	01.01.2007
Glaxo Wellcome Plc	Corporate Officer/Principal	-	-
Xenova Group Plc Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK	Corporate Officer/Principal	-	-

The University of Liverpool

Doctorate Degree

International

Vereinigtes Königreich

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
OXFORD NANOPORE TECHNOLOGIES PLC	Electronic Technology

Private Unternehmen	3
Xenova Group Plc Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK	Commercial Services
Glaxo Wellcome Plc	Health Technology
Solexa Ltd. Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK.	Health Technology